dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Fernandez Lopez, Cristina |
dc.contributor.author | Calleja‐Hernández, Miguel Ángel |
dc.contributor.author | Espín Balbino, Jaime |
dc.contributor.author | Cabeza Barrera, Jose |
dc.contributor.author | Expósito‐Hernández, José |
dc.date.accessioned | 2019-05-21T10:33:09Z |
dc.date.available | 2019-05-21T10:33:09Z |
dc.date.issued | 2019-03-13 |
dc.identifier.citation | Fernández‐López C, Calleja‐Hernández MÁ, Balbino JE, Cabeza‐Barrera J, Expósito‐Hernández J. Trends in endpoint selection and result interpretation in advanced non‐small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study. Thorac Cancer. 2019;10(4):904–8. |
dc.identifier.issn | 1759-7706 |
dc.identifier.uri | https://hdl.handle.net/11351/4079 |
dc.description | Càncer pulmonar de cèl·lules no petites; Avaluació de resultats (sanitat); Qualitat de vida |
dc.language.iso | eng |
dc.publisher | Wiley Open Access |
dc.relation.ispartofseries | Thoracic Cancer;10(4) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Estadístiques |
dc.subject | Anàlisi de supervivència (Biometria) |
dc.subject | Assaigs clínics |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | /statistics & numerical data |
dc.subject.mesh | Survival Analysis |
dc.subject.mesh | Clinical Trial, Phase III |
dc.title | Trends in endpoint selection and result interpretation in advanced non-small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1111/1759-7714.13024 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | /estadística & datos numéricos |
dc.subject.decs | análisis de supervivencia |
dc.subject.decs | ensayo clínico fase III |
dc.relation.publishversion | https://onlinelibrary.wiley.com/doi/full/10.1111/1759-7714.13024 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Fernández-López C] Servei de Farmàcia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Calleja-Hernández MÁ] Department of Pharmacy, Pharmacy Clinical Management Unit (UGC), Virgen Macarena University Hospital, Seville, Spain. [Espín Balbino J] Andalusian School of Public Health (EASP), Granada, Spain.Health Research Institute of Granada (ibs.GRANADA), University Hospitals of Granada, Granada, Spain. University of Granada, Granada, Spain. [Cabeza-Barrera J] Department of Pharmacy, Biosanitary Research Institute of Granada, San Cecilio University Hospital, Granada, Spain. [Expósito-Hernández J] Department of Oncology, University Hospitals of Granada, Health Research Institute of Granada (ibs.GRANADA), Granada, Spain. |
dc.identifier.pmid | 30868737 |
dc.identifier.wos | WOS:000465162800038 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |